Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for DAP.DE and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for DAP.DE and 80,000+ other tickers.
See exactly how DAP.DE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DAP.DE and 80,000+ other tickers.
Danaher Corporation is a global enterprise that develops, produces, and sells a diverse range of specialized products and services tailored for the professional, healthcare, industrial, and commercial sectors. Its operations are organized into three primary divisions: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences division delivers cutting-edge tools and solutions such as mass spectrometers, flow cytometry systems, genomics platforms, laboratory automation, centrifuges, particle analysis equipment, microscopes, and consumables for genomics, alongside Gene…
No recent news available.